🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Join Dr. Adriana Rossi Icahn School of Medicine at Mount Sinai and Dr. Benjamin Derman for #MultipleMyeloma updates from #ASCO25. bit.ly/4l44ORZ Multiple Myeloma RF

Accelerating progress in immunotherapy: mountsinai.org/about/newsroom… Cancer Research Institute Dr. Thomas Marron, Miriam Merad, MD, PhD Icahn School of Medicine at Mount Sinai

.Joshua Brody, MD, Brown Lab, Theodora Anagnostou, MD and colleagues analyze cancer vaccine trials and different vaccine approaches, and discuss how the next generation of cancer vaccines can help improve patient outcomes and quality of life. authors.elsevier.com/a/1lHcZV-4XSfX Icahn School of Medicine at Mount Sinai

Simcere Zaiming Announces First Patient Dosed in the US in a Phase 1 Trial of Trispecific Antibody SIM0500 in Pati... prn.to/4ebXMIE Joshua Richter, MD, FACP, is site PI at Mount Sinai Health System, Icahn School of Medicine at Mount Sinai. #MultipleMyeloma

.Joshua Brody, MD discusses the clinical significance of the long-term results from the EPCORE NHL-2 (NCT04663347) trial for patients with B-cell non-Hodgkin lymphoma. lymphomahub.com/medical-inform… Icahn School of Medicine at Mount Sinai #Lymphoma

Mount Sinai’s OCCAM Immune and the Cancer Research Institute (CRI) are joining forces to improve outcomes in cancer immunotherapy. Together, we aim to unlock deeper insights into how the immune system responds to treatment—starting with a clinical trial focused on aggressive

ajmc.com/view/long-term… via @AJMC Sundar Jagannath explains findings and implications for future research and patient care. #MultipleMyeloma Icahn School of Medicine at Mount Sinai

ajmc.com/view/phase-1-t… via @AJMC with John Mascarenhas Icahn School of Medicine at Mount Sinai

ajmc.com/view/next-step… via @AJMC With John Mascarenhas, MD, Icahn School of Medicine at Mount Sinai

ascopost.com/video-roundtab… With Virginia Corbett Icahn School of Medicine at Mount Sinai and colleagues

.Adam Kittai reports on Richter transformation and is leading a new clinical trial of CAR-T cell therapy along the BTK inhibitor zanubrutinib. mountsinai.org/about/newsroom… Icahn School of Medicine at Mount Sinai

New from Josep Llovet, MD, PhD, Icahn School of Medicine at Mount Sinai #livercancer #immunotherapy

AACR Past President and #AACRFellows Dr. Elizabeth Jaffee, Association of American Cancer Institutes Past President and AACR member Dr. George Weiner, and #AACRFellows Dr. Steven Rosenberg spoke with CBS Sunday Morning 🌞 about the devastating impact of NIH cuts on cancer research. brnw.ch/21wTNt3

onclive.com/view/dr-mascar… via @onclive with John Mascarenhas, MD, Icahn School of Medicine at Mount Sinai

.Adam Kittai publishes three studies advancing treatment for rare and aggressive lymphoma medicalxpress.com/news/2025-06-p… via Medical Xpress Icahn School of Medicine at Mount Sinai #CLL

onclive.com/view/fda-appro… via @onclive #MultipleMyeloma

We are pleased to host 3 medical students participating in The Robert A. Winn Excellence in Clinical Trials: Clinical Investigator Pathway Program (Winn CIPP). winnawards.org/2025/07/winn-c… VCU Massey Comprehensive Cancer Center Our faculty mentors: Deborah Marshall, MD; Melissa Mazor, PhD Icahn School of Medicine at Mount Sinai

As I step down as @iuis president, I reflect on the achievements of immunology science & challenges ahead, and call on scientists to reclaim the narrative on science and explain with "humility &clarity" science’s contribution to global health & prosperity👉loom.ly/iZseYbQ

New Bispecific T-Cell Engager Approved for Multiple Myeloma medpagetoday.com/hematologyonco… "Lynozyfic demonstrated early, deep and durable responses in heavily pretreated patients, which I saw firsthand in clinical trials," said Sundar Jagannath Icahn School of Medicine at Mount Sinai. #MultipleMyeloma

Latino Patients Less Likely to Receive Guideline-Recommended CLL Therapieshttps://www.physiciansweekly.com/latino-patients-less-likely-to-receive-guideline-recommended-cll-therapies/ With Adam Kittai Icahn School of Medicine at Mount Sinai